Protara Therapeutics market cap TARA
Share price times shares outstanding: what the whole company sells for, since 2014.
- Today, Nov 2, 2026
- $142.4M
- Highest close in our data
- $329M
- Jul 2015
Protara Therapeutics is worth $142.4M at the close on Nov 2, 2026, at $2.41 a share.
That is down 14% over the last year and up 78% over five years.
Its highest close in our data was $329M in Jul 2015.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $142.4M | $137.1M | $294.2M | −33% |
| 2025 | $214.2M | $76.7M | $284.8M | +88% |
| 2024 | $113.7M | $21.7M | $123.4M | +432% |
| 2023 | $21.4M | $13.1M | $43.6M | −29% |
| 2022 | $30.2M | $29.4M | $71.6M | −60% |
| 2021 | $75.8M | $70.7M | $244.5M | −72% |
| 2020 | $271.4M | $9.2M | $317.9M | +3750% |
| 2019 | $7.1M | $4.9M | $70M | −84% |
| 2018 | $43.2M | $28M | $48.6M | +29% |
| 2017 | $33.5M | $20.1M | $46.7M | +6% |
| 2016 | $31.5M | $31.5M | $194M | −88% |
| 2015 | $255.7M | $171.9M | $329M | +58% |
| 2014 | $161.5M | $144.3M | $173.4M | n/a |
Against its peers
Companies in Healthcare nearest Protara Therapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| TARAProtara Therapeutics | $142.4M |
| PDEXPro DEX | $184.5M |
| PLXProtalix BioTherapeutics | $206.3M |
| KEQUKewaunee Scientific | $96.7M |
| ICCCImmucell | $95.9M |
| NATRNatures Sunshine Products | $211.5M |
| ELMDElectromed | $223.9M |
| UTMDUtah Medical Products | $224.6M |
| INFUInfuSystem | $275.7M |
| LFVNLifevantage | $73.5M |
| CYHCommunity Health Systems | $296.2M |
| Peer median | $208.9M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Protara Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.